Van ECK Associates Corp Lowers Stock Position in Smith & Nephew plc (NYSE:SNN)

Van ECK Associates Corp lessened its holdings in Smith & Nephew plc (NYSE:SNN) by 42.2% in the 3rd quarter, Holdings Channel.com reports. The firm owned 4,375 shares of the medical equipment provider’s stock after selling 3,199 shares during the quarter. Van ECK Associates Corp’s holdings in Smith & Nephew were worth $128,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Mather Group LLC. lifted its position in Smith & Nephew by 9,735.3% during the second quarter. Mather Group LLC. now owns 1,672 shares of the medical equipment provider’s stock valued at $42,000 after acquiring an additional 1,655 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its position in Smith & Nephew by 1,894.3% during the second quarter. Allspring Global Investments Holdings LLC now owns 1,735 shares of the medical equipment provider’s stock valued at $43,000 after acquiring an additional 1,648 shares during the last quarter. GAMMA Investing LLC lifted its position in Smith & Nephew by 160.0% during the third quarter. GAMMA Investing LLC now owns 2,257 shares of the medical equipment provider’s stock valued at $70,000 after acquiring an additional 1,389 shares during the last quarter. EverSource Wealth Advisors LLC lifted its position in Smith & Nephew by 92.5% during the second quarter. EverSource Wealth Advisors LLC now owns 2,454 shares of the medical equipment provider’s stock valued at $61,000 after acquiring an additional 1,179 shares during the last quarter. Finally, Headlands Technologies LLC lifted its position in Smith & Nephew by 225.0% during the first quarter. Headlands Technologies LLC now owns 3,851 shares of the medical equipment provider’s stock valued at $98,000 after acquiring an additional 2,666 shares during the last quarter. Hedge funds and other institutional investors own 25.64% of the company’s stock.

Smith & Nephew Trading Up 0.1 %

Shares of Smith & Nephew stock opened at $24.61 on Thursday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.11 and a current ratio of 2.51. Smith & Nephew plc has a 12-month low of $23.65 and a 12-month high of $31.72. The firm’s 50 day simple moving average is $29.12 and its two-hundred day simple moving average is $27.87.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on SNN shares. Berenberg Bank cut shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research report on Wednesday, November 6th. Deutsche Bank Aktiengesellschaft lowered shares of Smith & Nephew from a “buy” rating to a “hold” rating in a research note on Friday, November 1st. Finally, StockNews.com lowered shares of Smith & Nephew from a “strong-buy” rating to a “buy” rating in a research note on Tuesday. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold”.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.